ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 220 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,996 | +17.7% | 6,732 | +52.3% | 0.04% | +50.0% |
| Q2 2023 | $203,895 | -79.9% | 4,420 | -68.4% | 0.03% | -82.9% |
| Q1 2022 | $1,015,000 | +42.4% | 13,982 | +87.0% | 0.18% | +41.1% |
| Q2 2021 | $713,000 | +216.9% | 7,478 | +277.9% | 0.12% | +313.3% |
| Q1 2021 | $225,000 | -85.6% | 1,979 | -82.5% | 0.03% | -85.3% |
| Q4 2020 | $1,567,000 | +15.9% | 11,317 | -31.2% | 0.20% | +17.9% |
| Q3 2020 | $1,352,000 | +37.0% | 16,450 | -25.9% | 0.17% | +32.1% |
| Q1 2020 | $987,000 | -14.4% | 22,207 | -17.7% | 0.13% | -31.4% |
| Q4 2019 | $1,153,000 | – | 26,995 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |